Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes.
Clinical Therapeutics（2019）
摘要
Insulin degludec is unlikely to be cost-effective compared with insulin glargine for Chinese patients with T2DM whose disease is inadequately controlled with oral antidiabetic drugs.
更多查看译文
关键词
Chinese,Cost-effectiveness,Insulin degludec,Insulin glargine,Type 2 diabetes mellitus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要